clioquinol has been researched along with alpha-synuclein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Adlard, PA; Arthofer, E; Billings, JL; Bush, AI; Culvenor, JG; Finkelstein, DI; George, S; Hare, DJ; Nurjono, M; Sedjahtera, A | 1 |
| Genov, M; Hummel, T; Kasture, A; Krenn, L; Moloney, M; Pretsch, A; Pretsch, D; Rollinger, JM; Schmid, A; Wöhrer, T | 1 |
| Bezard, E; Bohic, S; Dehay, B; Doudnikoff, E; Teil, M; Thiolat, ML | 1 |
3 other study(ies) available for clioquinol and alpha-synuclein
| Article | Year |
|---|---|
Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice.
Topics: alpha-Synuclein; Animals; Brain; Clioquinol; Cognition Disorders; Disease Models, Animal; Exploratory Behavior; Humans; Maze Learning; Mice; Mice, Transgenic; Movement Disorders; Mutation; Protein Aggregation, Pathological; Recognition, Psychology; Silver Staining; Spatial Learning | 2016 |
Prolongation of metallothionein induction combats Aß and α-synuclein toxicity in aged transgenic Caenorhabditis elegans.
Topics: Aging; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Benzothiazoles; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Clioquinol; Disease Models, Animal; Emodin; Gene Knockdown Techniques; Homeostasis; Metallothionein; Metals; Neuroprotective Agents; Parkinson Disease; Quercetin; Signal Transduction | 2020 |
The Zinc Ionophore Clioquinol Reduces Parkinson's Disease Patient-Derived Brain Extracts-Induced Neurodegeneration.
Topics: alpha-Synuclein; Animals; Brain; Clioquinol; Dopamine; Dopaminergic Neurons; Humans; Ionophores; Mice; Parkinson Disease; Substantia Nigra; Tissue Extracts; Zinc | 2022 |